In a cohort of 38 t-MDS/AML patients, TP53 mutation and loss of the TP53 locus occurred in 21% and 15% of patients, respectively, which were correlated with worse OS compared to those with wild-type TP53 [304]. The gene discussed is TP53; the disease is acute myeloid leukemia.